signific
consequ
equin
arter
viru
eav
infect
hors
persist
viru
variabl
percentag
infect
stallion
recent
establish
vitro
model
eav
persist
cell
cultur
purpos
further
understand
eav
biolog
gener
viral
persist
stallion
particular
studi
investig
whether
persist
infect
hela
cell
could
cure
eav
infect
treatment
antisens
peptideconjug
phosphorodiamid
morpholino
oligom
ppmo
design
target
termin
region
eav
genom
found
persist
infect
hela
cell
passag
three
time
presenc
eavspecif
ppmo
produc
detect
viru
ppmocur
hela
cell
free
infecti
viru
viral
antigen
eav
rna
measur
plaqu
assay
indirect
immunofluoresc
assay
rtpcr
respect
furthermor
rechalleng
eav
sever
passag
discontinu
ppmo
treatment
ppmocur
hela
cell
found
refractori
reinfect
reestablish
viral
persist
find
demonstr
ppmo
use
elimin
persist
eav
infect
cell
cultur
efficaci
ppmo
eav
vivo
remain
address
elsevi
bv
right
reserv
equin
arter
viru
eav
envelop
viru
singlestrand
positivesens
rna
genom
approxim
kb
belong
famili
arterivirida
order
nidoviral
cavanagh
snijder
meulenberg
genom
rna
compris
nine
known
open
read
frame
orf
flank
untransl
region
utr
snijder
meulenberg
snijder
et
al
two
proxim
orf
encod
two
replicas
polyprotein
remain
seven
orf
locat
proxim
onequart
genom
encod
envelop
protein
e
nucleocapsid
protein
n
respect
snijder
spaan
eav
caus
agent
equin
viral
arter
eva
wide
distribut
equin
popul
throughout
world
timoney
mccollum
variabl
percentag
stallion
acut
infect
eav
becom
persist
infect
carrier
shed
viru
constantli
semen
timoney
mccollum
persist
infect
stallion
princip
reservoir
eav
respons
perpetu
dissemin
eav
equin
popul
timoney
timoney
mccollum
timoney
et
al
longterm
carrier
state
stallion
allow
gener
genet
phenotyp
divers
eav
balasuriya
et
al
hedg
et
al
evid
establish
mainten
carrier
state
stallion
testosteronedepend
howev
mani
aspect
biolog
immunolog
underli
viral
persist
remain
elucid
holyoak
et
al
littl
et
al
mccollum
et
al
despit
signific
biolog
econom
consequ
persist
eav
infect
date
fulli
valid
therapeut
strategi
except
surgic
castrat
elimin
carrier
state
timoney
mccollum
phosphorodiamid
morpholino
oligom
pmo
compris
class
singlestrand
oligonucleotid
analogu
contain
purin
pyrimidin
base
dna
possess
backbon
compos
morpholin
ring
phosphorodiamid
intersubunit
linkag
instead
deoxyribos
phosphodiest
compon
dna
pmo
act
antisens
agent
watsoncrick
base
pair
complementari
rna
target
sequenc
thu
form
steric
blockad
interf
gene
express
summerton
pmo
watersolubl
nucleaseresist
typic
synthes
subunit
length
summerton
coval
conjug
argininerich
cellpenetr
peptid
cpp
pmo
terminu
found
greatli
improv
deliveri
pmo
cell
abe
et
al
dea
et
al
moulton
et
al
peptideconjug
pmo
ppmo
shown
inhibit
amplif
number
rna
virus
cell
cultur
mous
model
review
stein
includ
arteriviru
porcin
reproduct
respiratori
syndrom
viru
han
et
al
patel
et
al
patel
et
al
zhang
et
al
coronavirus
mous
hepat
viru
sarscov
burrer
et
al
neuman
et
al
neuman
et
al
previou
studi
prrsv
patel
et
al
eav
van
den
born
et
al
shown
ppmo
target
termin
region
respect
arterivir
genom
particularli
effect
inhibit
viru
infect
van
den
born
et
al
conclud
mechan
action
eav
utrdirect
ppmo
suppress
viru
product
like
inhibit
translat
recent
establish
vitro
model
eav
persist
hela
cell
purpos
further
understand
eav
biolog
gener
viral
persist
stallion
particular
zhang
et
al
b
object
current
studi
investig
whether
eavspecif
ppmo
could
effect
elimin
viru
persist
infect
hela
cell
studi
employ
antisens
ppmo
target
termin
region
eav
genom
nucleotid
posit
vb
strain
eav
genbank
access
number
random
sequenc
neg
control
ppmo
scr
cpp
rxr
xb
r
arginin
x
acid
b
betaalanin
coval
conjug
end
pmo
synthesi
purif
analysi
ppmo
scr
ppmo
perform
avi
biopharma
inc
corval
use
method
previous
describ
abe
et
al
summerton
weller
potenti
cytotox
ppmo
evalu
normal
helah
cell
helah
cell
persist
infect
eav
briefli
normal
helah
persist
infect
helah
cell
approxim
cell
subcultur
ml
serumfre
eagl
minimum
essenti
medium
emem
contain
ppmo
scr
ppmo
concentr
plate
condit
design
mirror
antivir
experi
h
treatment
c
ml
emem
contain
bovin
calf
serum
ad
cell
viabil
determin
compar
ppmotreat
mocktreat
cell
h
h
posttreat
use
vicel
xr
beckman
coulter
california
autom
cell
viabil
analysi
base
trypan
blue
vital
dye
exclus
method
condit
cytotox
observ
normal
helah
persist
infect
helah
cell
follow
treatment
either
ppmo
three
concentr
test
data
shown
subsequ
effect
ppmo
helah
cell
persist
infect
eav
investig
serial
passag
eavpersist
infect
helah
cell
line
grown
plate
subcultur
everi
day
passag
passag
presenc
ppmo
scr
ppmo
concentr
passag
level
cell
first
subcultur
h
ml
serumfre
emem
contain
respect
concentr
ppmo
ppmo
follow
addit
ml
emem
contain
bovin
calf
serum
tissu
cultur
supernat
passag
level
harvest
evalu
infecti
viru
plaqu
assay
rabbit
kidney
cell
atcc
describ
previous
mccollum
et
al
standard
rtpcr
srtpcr
realtim
rtpcr
rrtpcr
analys
rna
extract
cell
lysat
also
carri
passag
level
follow
previous
describ
procedur
balasuriya
et
al
gilbert
et
al
lu
et
al
indirect
immunofluoresc
assay
ifa
perform
select
passag
level
cell
use
monoclon
antibodi
mab
eav
nonstructur
wagner
et
al
mab
eav
nucleocapsid
n
protein
maclachlan
et
al
follow
fluoresceinconjug
goat
antimous
immunoglobulin
pierc
accord
previous
describ
procedur
zhang
et
al
shown
fig
persist
infect
helah
cell
receiv
treatment
ppmo
produc
infecti
viru
titer
similar
untreat
cell
throughout
observ
period
passag
contrast
viru
persist
infect
cell
cultur
receiv
treatment
ppmo
gradual
decreas
titer
first
three
passag
infecti
viru
detect
ie
passag
onward
parallel
result
obtain
eav
rna
measur
srtpcr
rrtpcr
cell
lysat
persist
infect
helah
cell
either
untreat
treat
ppmo
posit
eav
rna
passag
fig
wherea
cell
treat
ppmo
posit
eav
rna
passag
eav
rna
detect
passag
onward
fig
repres
srtpcr
rrtpcr
result
shown
fig
respect
persist
infect
helah
cell
receiv
variou
concentr
scr
ppmo
ppmo
continu
produc
eav
rna
infecti
viru
throughout
durat
studi
although
fluctuat
viral
titer
observ
time
fig
ifa
evalu
carri
select
passag
level
cell
receiv
ppmo
scr
ppmo
ppmo
ifa
result
passag
depict
fig
f
cell
receiv
ppmo
scr
ppmo
robustli
express
eav
nonstructur
fig
c
structur
fig
protein
wherea
cell
receiv
ppmo
produc
detect
nonstructur
fig
structur
fig
protein
determin
viru
product
would
resum
cultur
discontinu
effect
ppmo
treatment
describ
ppmo
treatment
stop
passag
set
replic
cultur
receiv
ppmo
cultur
pass
seven
time
without
ppmo
treatment
passag
absenc
ppmo
treatment
result
product
renew
viral
rna
viral
antigen
infecti
viru
measur
srtpcr
rrtpcr
ifa
plaqu
assay
respect
repres
rtpcr
ifa
result
ppmocur
cell
shown
fig
fig
h
togeth
find
demonstr
eav
infect
elimin
persist
infect
helah
cell
passag
presenc
ppmo
result
also
confirm
import
termin
region
genom
amplificationcycl
eav
van
den
born
et
al
previou
studi
demonstr
virul
bucyru
vb
strain
eav
viru
recov
b
scr
ppmo
c
ppmo
e
f
passag
subject
ifa
respect
use
mab
eav
protein
mab
eav
nucleocapsid
protein
follow
fluoresceinconjug
goat
antimous
immunoglobulin
cell
nucleu
stain
hoechst
blue
color
also
includ
ifa
imag
ppmocur
helah
cell
ppmo
treatment
stop
passag
g
h
interpret
refer
color
figur
legend
reader
refer
web
version
articl
passag
persist
infect
helah
cell
could
readili
establish
persist
infect
normal
helah
cell
zhang
et
al
mind
decid
investig
growth
kinet
vb
virus
helah
cell
cure
viru
persist
ppmo
treatment
addit
investig
persist
infect
either
two
virus
could
reestablish
ppmocur
helah
cell
shown
fig
substanti
increas
infecti
viru
titer
observ
vband
helah
cell
vb
log
increas
log
increas
contrast
viru
titer
increas
substanti
ppmocur
helah
cell
inocul
either
vb
viru
consist
previou
find
persist
infect
could
establish
normal
helah
cell
vb
virus
fig
contrast
persist
infect
could
establish
either
viru
strain
ppmocur
helah
follow
h
adsorpt
c
cell
monolay
wash
three
time
pb
ml
fresh
cultur
medium
ad
inocul
cultur
incub
c
subcultur
everi
day
tissu
cultur
supernat
serial
subcultur
passag
harvest
titrat
viru
plaqu
assay
averag
result
three
experi
shown
cell
although
low
titer
viru
could
detect
two
passag
vbinocul
five
passag
cell
fig
result
demonstr
ppmocur
helah
cell
significantli
less
recept
normal
helah
cell
reinfect
eav
factor
contribut
greatli
reduc
suscept
ppmocur
helah
cell
reinfect
eav
reestablish
viru
persist
remain
elucid
ppmocur
helah
cell
evalu
studi
obtain
treatment
persist
infect
cell
ppmo
seven
passag
follow
seven
passag
without
ppmo
treatment
therefor
unlik
residu
ppmo
made
cell
resist
reinfect
eav
would
interest
compar
express
level
eav
receptor
ppmocur
helah
cell
present
normal
helah
cell
unfortun
cellular
receptor
involv
eav
infect
yet
clearli
identifi
ppmo
target
viral
sequenc
shown
inhibit
amplif
number
rna
virus
vitro
vivo
review
stein
howev
antivir
studi
ppmo
report
date
limit
acut
viral
infect
model
studi
investig
effect
ppmo
helah
cell
persist
infect
eav
treatment
antisens
ppmo
target
eav
terminu
concentr
elimin
viru
persist
infect
helah
cell
cell
confirm
free
eav
eav
nucleic
acid
subsequ
passag
absenc
ppmo
although
result
indic
ppmo
elimin
persist
eav
infect
cell
cultur
efficaci
ppmo
eav
vivo
remain
evalu
unfortun
satisfactori
small
anim
model
eav
infect
exist
investig
possibl
elimin
carrier
state
stallion
ppmo
sever
complex
issu
would
need
address
includ
potenti
toxic
therapeut
relev
level
ppmo
equin
deliveri
effect
dose
ppmo
equin
male
reproduct
tract
nevertheless
result
vitro
studi
suggest
consider
vivo
investig
may
warrant
